- Centers & Specialties
- Clinical Interests
- Stem cells
- Regenerative medicine
- Hematologic malignancies
- Medical Education
- MD, Case Western Reserve University School of Medicine
- Residency, Brigham and Women's Hospital
- Fellowship, Brigham and Women's Hospital|Fellowship, Dana Farber Cancer Institute
- Board Certifications
- Internal Medicine
- Medical Oncology
- Boston: Massachusetts General Hospital
- Insurances Accepted
- Aetna Health Inc.
- Beech Street
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- Cigna (PAL #'s)
- Fallon Community HealthCare
- Great-West Healthcare (formally One Health Plan)
- Harvard Pilgrim Health Plan - ACD
- Harvard Pilgrim Health Plan - PBO
- Health Care Value Management (HCVM)
- Humana/Choice Care PPO
- Medicare - ACD
- Neighborhood Health Plan - ACD
- Neighborhood Health Plan - PBO
- OSW - Maine
- OSW - New Hampshire
- OSW - Rhode Island
- Private Health Care Systems (PHCS)
- Senior Whole Health
- Tufts Health Plan
- United Healthcare (non-HMO) - ACD
- United Healthcare (non-HMO) - PBO
- Patient Age Group
- Research Summary
- My interest is in understanding how stem cell biology can be used to develop more effective therapies for blood diseases and cancer.
The 69th meeting of the MGH Scientific Advisory Committee (SAC), on April 6 and 7, focused on the hospital's five thematic research centers.
A study comparing how blood stem cells and leukemia cells consume nutrients found that cancer cells are far less tolerant to shifts in their energy supply than their normal counterparts. The results suggest that there could be ways to target leukemia metabolism so that cancer cells die but other cell types are undisturbed.
In General awards and honors
MGH Hotline 5.27.11
MGH Hotline 12.24.10 In General awards and honors
MGH Hotline 08.06.10 In General awards and honors
MGH investigators have identified a new mechanism that controls the number of the stem cells that give rise to all blood and immune system cells, an advance that may improve treatment of blood system cancers.
MGH Hotline 05.14.10 Researchers from the Center for Regenerative Medicine gathered with Cheryl Chagnon, Heather Reid and their families April 6 to celebrate the donation of an important piece of research equipment -- the Nexelcom Cellometer Vision automatic cell analyzer.
A new study by Harvard researchers at Massachusetts General Hospital indicates that "good" cells can become cancerous because of exposure to a "bad" environment within the body — similarly to the way a "good boy" may turn to crime when exposed to the pressures of life in a crime-ridden neighborhood.
Dr. David Scadden shares his thoughts on the new executive order.
Harvard Stem Cell Institute
185 Cambridge Street
Boston MA, 02114
Phone 1: 617-726-5615